14th Biennial Congress of the Anaerobes Society of the Americas

项目摘要 厌氧菌，即在无氧条件下茁壮成长的细菌，既是疾病的主要贡献者，也是 对人类健康至关重要。虽然艰难梭菌是一种严重的传染病威胁，也是导致 对于与医疗保健相关的感染，我们越来越意识到厌氧菌以有益的方式有助于 人类微生物群的结构和功能。尽管地区性学会专注于厌氧菌 细菌科学存在于国外选定的地点(如英国、日本)、美洲厌氧菌协会 美国厌氧菌学会(ASA)是美国唯一致力于厌氧菌基础和临床科学的学会。此外， 长期以来，ASA一直拥有活跃的国际成员，来自30多个国家和地区的代表参加了 2016年两年一度的大会。协会及其两年一次的大会(成立于1992年)的长期目标是 通过研究厌氧细菌及其环境来促进健康和促进科学进步。这 提案寻求NIH对厌氧菌的支持，这是将主办的ASA第14届两年一度的大会 2018年7月9日至12日，内华达州拉斯维加斯。第十四届两年一度的大会的具体目标是：(1)刺激 对厌氧运动的兴趣，并鼓励和促进来自所有学科的无氧运动运动员之间的交流， 包括医学、牙科、兽医、微生物学和基础科学研究领域； 了解微生物区系及其对健康疾病的贡献；(3)讨论争议和 梭状芽胞杆菌致病研究进展及抗菌药日益增多的问题 艰难梭菌、类杆菌和其他厌氧细菌的耐药性；以及(4)探索新出现的 益生菌开发和临床应用中的作用机制、健康益处和监管问题 微生物区系转移。第十四届两年一度的大会将通过由超过 20位国内外专家科学演讲嘉宾及多种演讲形式。组织者 委员会已经创建了一个计划，促进厌氧菌参与者和与会者之间的多样性 2018年。会议只有一个房间，亲密的性质将鼓励真诚的，面对面的， 通常不会在任何其他会议上会面的科学家之间的跨学科交流 会场。与NIH和NIAID的目标一致，ASA第14届两年一度的大会提供了 将世界领先的厌氧菌细菌基础和临床研究人员聚集在一起的独特机会 科学及其翻译促进了对人类健康具有持久影响的研究。

Project Summary Anaerobes, bacteria that thrive in the absence of oxygen, are both major contributors to disease as well as critical to human health. While Clostridium difficile is a serious infectious disease threat and a leading cause of healthcare-associated infections, we are increasingly aware that anaerobes contribute in a beneficial way to the structure and function of the human microbiome. Although regional Societies focused on anaerobe bacterial science exist in select locales abroad (e.g., Britain, Japan), the Anaerobe Society of the Americas (ASA) is the only United States-based Society devoted to the basic and clinical science of anaerobes. Further, the ASA has long had an active international membership with representation from more than 30 countries at the 2016 Biennial Congress. The long-term goal of the ASA and its biennial congress (founded in 1992) is to promote health and advance science through the study of anaerobic bacteria and their environments. This proposal seeks NIH support for ANAEROBE 2018, the 14th Biennial Congress of the ASA, which will be hosted from July 9-12, 2018 in Las Vegas, NV. The specific aims of the 14th Biennial Congress are: (1) to stimulate interest in anaerobes and to encourage and facilitate interchange among anaerobists from all disciplines, including medical, dental, veterinary, microbiology and basic sciences fields of study; (2) to assess our current understanding of the microbiota and its contribution to health disease; (3) to discuss controversies and advances in disease induction by Clostridium species and grapple with the increasing problem of antimicrobial resistance in C. difficile, Bacteroides species, and other anaerobic bacteria; and (4) to probe emerging mechanisms of action, health benefits, and regulatory issues in probiotic development and clinical use of microbiota transfer. The 14th Biennial Congress will accomplish this goal through presentations by more than 20 domestic and international expert scientific speakers and a variety of presentation formats. The Organizing Committee has created a program that fosters diversity among the participants and attendees at ANAEROBE 2018. The one-room, intimate nature of the conference will encourage a hearty, person-to-person, interdisciplinary exchange between scientists who do not generally meet together in any other conference venue. Consistent with the goals of the NIH and NIAID, the 14th Biennial Congress of the ASA provides a unique opportunity to bring together the world’s leading basic and clinical investigators in anaerobe bacterial science and its translation toadvance studies with lasting impact on human health.!